|
September 2006
Molecular imaging brings the vision of personalized medicine into focus
MI identifies variations in disease expression and therapeutic responsiveness for better clinical decision-making Read More » Scientific discovery adds spice to Britton Chance's long life
Dr. Britton Chance is one of the most inventive people in biomedical imaging. Read More » SUVs earn cheers for research but jeers for routine clinical use
In the quantitative world of molecular imaging, the standardized uptake value (SUV) looms large as a key measure of tumor aggressiveness and therapeutic response. Read More » MDs prove slow to adopt FDG-PET for cervical cancer staging
MI techniques recommend against unnecessary surgeries and monitor therapy Read More » Informatics sifts complex MI data
Computer tools guide research and streamline interpretation of clinical imaging results Read More » SPIO agents undergo scrutiny for cell tracking
Researchers weigh alternatives while they search for optimal ferric material Read More » Nuclear medicine embraces MI applications
Two top meetings showcase MI progress, while investment in basic sciences soars Read More » Combined approach evaluates breast cancer treatment progress
CONTEXT: Combining proton MR spectroscopic imaging, sodium MR, and PET/CT imaging may be an effective multimodality approach for detecting early response to chemotherapy in breast cancer patients, according to Dr. Michael Jacobs, a radiologist at Johns Hopkins School of Medicine. Read More » MRI tracks transplanted pancreatic cells labeled with iron-oxide contrast
The emerging therapy of islet transplantation has shown great promise for diabetes patients. Read More » Human trial of anti-F-18 FACBC tracer shows promise for prostate cancer
CONTEXT: While prostate-specific antigen testing and biopsy are the most conclusive ways for detecting prostate cancer, no clear-cut imaging technique exists for initial diagnosis and staging. Read More » Automated analysis of FDG-PET scans may predict rate of cognitive decline
FDG-PET imaging has become an accepted, reimburseable approach for diagnosing Alzheimer's and other neurodegenerative diseases. Read More » |
|
